Literature DB >> 3465838

Enhancement of human peripheral blood monocyte respiratory burst activity by aggregated C-reactive protein.

J M Zeller, A L Landay, T F Lint, H Gewurz.   

Abstract

We had previously demonstrated that C-reactive protein (CRP), an acute phase reactant, when aggregated or coupled to a ligand, interacts with monocytes and certain human peripheral blood lymphocytes. The purpose of the present study, after further characterizing the binding interaction of CRP with human monocytes, was to focus on the biological response of monocytes to CRP binding. Flow cytometric analysis of human mononuclear leukocytes, following incubation with fluoresceinated heat-aggregated CRP (Agg-CRP), revealed that while greater than 70% of monocytes bound Agg-CRP, only 8% of lymphocytes demonstrated positive fluorescence. Furthermore, mean channel fluorescence values indicated that monocytes bound greater amounts of Agg-CRP per cell than did lymphocytes. Luminol-enhanced chemiluminescence (CL) was used as a measure of monocyte respiratory burst activity. Monocytes were stimulated only minimally by Agg-CRP alone; however, Agg-CRP substantially enhanced the CL response to heat-aggregated IgG. This Agg-CRP enhancing effect was selective for IgG-initiated monocyte activation, as no augmentation in CL was observed following cell stimulation with phorbol myristate acetate or serum-opsonized zymosan. These results demonstrate that aggregated CRP binds to the major proportion of human monocytes and selectively augments Fc receptor-mediated stimulation of monocyte oxidative metabolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3465838     DOI: 10.1002/jlb.40.6.769

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  Effect of short-term aspirin use on C-reactive protein.

Authors:  D Feng; R P Tracy; I Lipinska; J Murillo; C McKenna; G H Tofler
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

2.  Changes in respiratory burst activity during human monocyte differentiation in suspension culture.

Authors:  J M Zeller; J Caliendo; T F Lint; D J Nelson
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

3.  Whole-cell currents in macrophages: I. Human monocyte-derived macrophages.

Authors:  D J Nelson; B Jow; F Jow
Journal:  J Membr Biol       Date:  1990-07       Impact factor: 1.843

4.  Evaluation of human monocyte oxidative metabolism utilizing a flow cytometric assay.

Authors:  J M Zeller; L Rothberg; A L Landay
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

Review 5.  C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.

Authors:  Terry W Du Clos; Carolyn Mold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

Authors:  H Jiang; T F Lint; H Gewurz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 7.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

8.  Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity.

Authors:  L A Potempa; J M Zeller; B A Fiedel; C M Kinoshita; H Gewurz
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

Review 9.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

10.  C-reactive protein protects against preerythrocytic stages of malaria.

Authors:  S Pied; A Nussler; M Pontent; F Miltgen; H Matile; P H Lambert; D Mazier
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.